ArticleCureus2025
Intramuscular Aseptic Cyst Syndrome: A Case Report and a Review of the Literature.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aseptic cyst syndrome (ACS) is a rare condition frequently associated with a systemic inflammatory response. The clinical presentation closely mimics an infection, making diagnosis and treatment challenging. The most common location of aseptic abscesses is intra-abdominal. Intramuscular involvement is highly uncommon, typically affecting muscles near the trunk. This report presents a case of a male patient who developed multiple aseptic abscesses in the hamstrings and proximal gastrocnemius (GM) muscles. The patient initially underwent surgical debridement and cyst resection, followed by intravenous antibiotic therapy. Although there was a brief period of improvement, a relapse occurred, marked by renewed pain, fever, elevated infection biomarkers, and knee joint effusion. The patient was ultimately treated with corticosteroids, followed by immunosuppressant therapy, resulting in rapid disease improvement. No recurrence was observed at the final follow-up, nine months after symptom onset. A narrative review of the literature on this topic is also included. This case underscores the importance of high clinical suspicion and a multidisciplinary approach in the diagnosis and management of ACS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.